Medipharm Labs Corp T.LABS

New Press Release - MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

TORONTO, Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for...read article.

[1hot-techwoman]

In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA

[piduks]

MPL isn't the only player in town with a DEL.  Tilray has one now also.  MPL has not released any news except for the Remidose royalty deal.    Where's the revenue growth going to come from?  ...someone has their foot on the neck of the FDA...can't wait for the 'clean sweep' and maybe a new fish pond in the court yard of those who think they have a big